House Energy and Commerce Committee questioned FDA Commissioner Margaret A. Hamburg about the agency's failure to communicate proactively with the Massachusetts Department of Public Health or to provide adequate oversight of the New England Compounding Center in Framingham, Mass., which has been implicated in 32 deaths and more than 400 additional illnesses from a fungal meningitis outbreak across 19 states.